Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John F.
Amarin Corporation plc (NASDAQ: AMRN) Q1 2020 Earnings Call Transcript
Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John F.
Illumina Inc (ILMN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Jacquie Ross -- Vice President of Corporate Communications and Corporate Social
Gilead Sciences Inc. (GILD) Q1 2020 earnings call dated April 30, 2020 Corporate Participants: Douglas Maffei -- Investor Relations Daniel O'Day -- Chairman and Chief Executive
Amgen's (NASDAQ: AMGN) top and bottom line in the first quarter of 2020 beat analysts' estimates. The biotech firm's adjusted earnings per
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Thursday said its first-quarter earnings increased, aided by higher revenues. The results also exceeded the
Abiomed Inc (ABMD) Q4 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Todd A.Trapp -- Vice President and Chief Financial Officer Michael R.
Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported a decline in fourth quarter earnings even as revenues remained flat. The company withheld
Cigna Corporation (NYSE: CI) reported first quarter 2020 earnings results today. Total revenues amounted to $38.5 billion, reflecting a slight increase from
Align Technology Inc (ALGN) Q1 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Shirley Stacy -- Vice President of Corporate Communications & Investor
Vertex Pharmaceuticals Inc (VRTX) Q1 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations Reshma
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter
Humana Inc. (HUM) Q1 2020 earnings call dated April 29, 2020 Corporate Participants: Amy Smith -- Investor Relations Bruce D. Broussard -- President and Chief Executive Officer
IQVIA Holdings Inc. (IQV) Q1 2020 earnings call dated Apr. 28, 2020 Corportate Participants: Andrew Markwick -- Senior Vice President, Investor Relations and Treasury
Anthem Inc. (NYSE: ANTM) reported a 2% decline in earnings for the first quarter of 2020 due to an increase in income
Boston Scientific Corporation (NYSE: BSX) announced first quarter 2020 earnings results today. Sales grew 2% to $2.54 billion compared to the same
Cerner Corp (CERN) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: David Brent Shafer -- Chairman andChief Executive Officer Marc Naughton -- Chief Financial
Waters Corporation (WAT) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Bryan Brokmeier -- CFA, Senior Director Christopher J. O'Connell -- President and Chief
Accuray Inc (ARAY) Q3 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Joseph Diaz -- Managing Partner Joshua H. Levine -- President and Chief Executive
Biotechnology is the one industry that has been showing signs of improvement in the COVID-19 affected market. This week a bunch of
Neogenomics Inc (NEO) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Douglas M. VanOort -- Chairman of the Board of Directors and
Pfizer Inc. (PFE) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert Bourla -- Chairman and